Insulin Packaging Research 
Pharmaceutical Technology
JULY 15, 2022
Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.
XTalks
NOVEMBER 17, 2021
While the line was initially launched in 2018 under the name “The Swedish Sugar Buster,” the re-launch features new packaging and flavors that are more suitable for today’s functional beverage market. According to market research from the IMARC Group , the global diabetic food market hit $9.2
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
AUGUST 1, 2024
per package in the US. Growing Interclass Drug Competition: The diabetes treatment market is highly competitive, comprising of various alternative therapies (including oral anti-diabetics, insulin, and other injectable medications); notably, the introduction of biosimilars is likely to impact the dynamics of this market.
The Pharma Data
JUNE 28, 2021
Medical Director, National Research Institute and Principal Investigator of SURPASS-2. Lilly intends to submit the full registration package to regulatory authorities by the end of 2021. Diabetes is a chronic disease that occurs when the body does not properly produce or use the hormone insulin.
The Pharma Data
JUNE 28, 2021
Director of the Dallas Diabetes Research Center at Medical City and Principal Investigator of SURPASS-1. Lilly intends to submit the full registration package to regulatory authorities by the end of 2021. Diabetes is a chronic disease that occurs when the body does not properly produce or use the hormone insulin.
The Pharma Data
AUGUST 3, 2021
– Second-quarter 2021 operating expenses increased 18 percent, driven primarily by higher research and development investments for late-stage assets, as well as higher relative marketing and selling expenses due to pandemic-related spending reductions in 2020. – Second-quarter 2021 earnings per share (EPS) decreased to $1.53
The Pharma Data
MAY 14, 2021
Plus, I’m going to show you all the research…. After stumbling upon this new breakthrough scientific research…. It also forces your body to release insulin…. It’s almost impossible to burn fat in the presence of insulin…. Because insulin BLOCKS AMPk. Your body releases insulin and resistin….
Expert insights. Personalized for you.
328 
Let's personalize your content